Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins

J Cell Physiol. 2010 Jul;224(1):195-204. doi: 10.1002/jcp.22122.

Abstract

Vascular endothelial-protein tyrosine phosphatase (VE-PTP) is a receptor-type protein tyrosine phosphatase with a single catalytic domain in its cytoplasmic region and multiple fibronectin type III-like domains in its extracellular region. VE-PTP is expressed specifically in endothelial cells and is implicated in regulation of angiogenesis. The molecular basis for such regulation by VE-PTP has remained largely unknown, however. We now show that forced expression of VE-PTP promoted cell spreading as well as formation of lamellipodia and filopodia in cultured fibroblasts plated on fibronectin. These effects of VE-PTP on cell morphology required its catalytic activity as well as activation of integrins and Ras. In addition, VE-PTP-induced cell spreading and lamellipodium formation were prevented by inhibition of Src family kinases or of Rac or Cdc42. Indeed, forced expression of VE-PTP increased the level of c-Src phosphorylation at tyrosine-416. Moreover, the VE-PTP-induced changes in cell morphology were suppressed by expression of dominant negative forms of FRG or Vav2, both of which are guanine nucleotide exchange factors for Rho family proteins and are activated by tyrosine phosphorylation. Forced expression of VE-PTP also enhanced fibronectin-dependent migration of cultured fibroblasts. Conversely, depletion of VE-PTP by RNA interference in human umbilical vein endothelial cells or mouse endothelioma cells inhibited cell spreading on fibronectin. These results suggest that VE-PTP, in cooperation with integrins, regulates the spreading and migration of endothelial cells during angiogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CHO Cells
  • Cell Line, Tumor
  • Cell Movement* / drug effects
  • Cell Shape* / drug effects
  • Cricetinae
  • Cricetulus
  • Endothelial Cells / drug effects
  • Endothelial Cells / enzymology*
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / drug effects
  • Fibroblasts / enzymology*
  • Fibronectins / metabolism
  • Guanine Nucleotide Exchange Factors / genetics
  • Guanine Nucleotide Exchange Factors / metabolism
  • Humans
  • Integrins / metabolism*
  • Mice
  • Mutation
  • Neovascularization, Physiologic* / drug effects
  • Phosphorylation
  • Proto-Oncogene Proteins c-vav / genetics
  • Proto-Oncogene Proteins c-vav / metabolism
  • Pseudopodia / enzymology
  • RNA Interference
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 / genetics
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3 / metabolism*
  • Transfection
  • Tyrosine
  • cdc42 GTP-Binding Protein / antagonists & inhibitors
  • cdc42 GTP-Binding Protein / metabolism
  • rac GTP-Binding Proteins / antagonists & inhibitors
  • rac GTP-Binding Proteins / metabolism
  • ras Proteins / genetics
  • ras Proteins / metabolism
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / metabolism

Substances

  • Enzyme Inhibitors
  • FGD1-related Cdc42-GEF protein, human
  • Fibronectins
  • Guanine Nucleotide Exchange Factors
  • Integrins
  • Proto-Oncogene Proteins c-vav
  • Vav2 protein, mouse
  • Tyrosine
  • src-Family Kinases
  • PTPRB protein, human
  • Ptprb protein, mouse
  • Receptor-Like Protein Tyrosine Phosphatases, Class 3
  • cdc42 GTP-Binding Protein
  • rac GTP-Binding Proteins
  • ras Proteins